Macromolecular Therapeutics Development Facility (MTDF) / Hybridoma Facility

Overview

The Macromolecular Therapeutics Development Facility (MTDF) provides expertise for directed development and optimization of protein-based therapeutics and supports high-throughput automated development, analysis and production of protein reagents using a Biomek FxP liquid handling workstation for HTP molecular biology and expression testing, a Perkin-Elmer Cell::Explorer robot for very efficient HTP tissue culture based application and a custom microarray printer. This automation is designed to provide Einstein researchers with the added leverage of robotics equipment and trained personnel to accelerate and scale up their projects, thereby obviating the need for individual investigators to set up and staff their own facilities for protein production.

 

The Hybridoma Facility produces mouse monoclonal antibodies to antigens provided by investigators. For most investigators, the staff of the facility carries out the entire process from mouse immunization through fusion for hybridoma generation, cloning, screening, production of monoclonal antibody (mAb), and freezing of cell lines for long-term storage. In general, facility staff meet with the Principal Investigator, or his or her representative, to discuss the scientific goals of the project and to make decisions regarding immunogen preparation, immunization strategy, screening for positive hybridomas once a fusion is completed, and the types of antibodies required. Investigators provide the antigen for immunization and screening, while the facility provides and maintains the mice and performs all steps from immunization through fusion, cloning, and primary screening.

 

Services

  • General cloning into a range of protein expression vectors (single through 96 well)
  • Expression profiling – E. coli, insect, mammalian
  • Large-scale and high-throughput growth of cells or bacteria expressing recombinant proteins
  • Classical and automated purification of recombinant proteins from culture supernatant
  • Custom DNA and cell microarrays
  • Generation of hybridomas making mouse and rat monoclonal antibodies
  • Generation of isotype switched monoclonal antibodies
  • High-content imaging via the Operetta CLS

Leadership

Steven C. Almo, Ph.D.
Scientific Director
steve.almo@einsteinmed.edu

Co-Scientific Director (Monoclonal Antibodies)
Matthew D. Scharff, M.D.
matthew.scharff@einsteinmed.edu

Steven Porcelli, M.D.
Scientific Director, Hybridoma Facility
steven.porcelli@einsteinmed.edu

 

Location and hours of operation

Hours Location

9 am - 5 pm

Monday - Friday   

1301 Morris Park Ave

Price Center, Room 313

Bronx, NY 10461

Links and Resources

  1. MTDF Grant Resource Document
  2. Hybridoma Grant Resource Document
  3. List of available scFv directed against heparan sulfate

Contacts

Name Role Phone Email Location
Scott J. Garforth, Ph.D.
Operations Director
 
718-678-1146
 
scott.garforth@einsteinmed.edu
 
Price Center, Room 274
 
Susan Buhl
Associate Director, Monoclonal Antibodies
 
718-430-2170
 
susan.buhl@einsteinmed.edu
 
Chanin, Room 404
 

Services


Search available services: View: by category alphabetically
Eukaryotic (27)
Prokaryotic (12)
Hybridoma Facility (21)
Molecular Biology (6)
Other Services (7)